Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3VM1001 Cream for Knee Osteoarthritis Pain
NCT03142178Phase 2Completed
- Sponsor
- CDA Research Group
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of 3VM1001 in osteoarthritis (OA), sponsored by CDA Research Group. Started Apr 2017; status: completed.
02
Drugs
3VM1001
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03142178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142178.